Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination

Joshua W Fleming, Laurie W Fleming, Courtney S Davis Department of Pharmacy Practice, The University of Mississippi School of Pharmacy, Jackson, MS, USA Abstract: Canagliflozin–metformin is one of the newest combination therapies available for the treatment of type 2 diabetes mellitus (T2...

Full description

Bibliographic Details
Main Authors:	Fleming JW, Fleming LW, Davis CS
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-06-01
Series:	Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Online Access:	http://www.dovepress.com/fixed-dose-combinations-in-type-2-diabetes-ndash-role-of-the-canaglifl-peer-reviewed-article-DMSO

Similar Items

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
by: Jonathan K Reynolds
Published: (2009-07-01)

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
by: Green J, et al.
Published: (2010-10-01)

Clinical utility of fixed combinations of sitagliptin&ndash;metformin in treatment of type 2 diabetes
by: Karen Barnard, et al.
Published: (2010-10-01)

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
by: Kuecker CM, et al.
Published: (2016-02-01)

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
by: Hayes J, et al.
Published: (2016-07-01)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
by: Robert Moses
Published: (2009-06-01)

Comparative Liquid Chromatographic Study for Concurrent Determination of Canagliflozin and Metformin in Combined Tablets
by: Wafaa A. Zaghary, et al.
Published: (2017-01-01)

Spotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic review
by: Kedia R, et al.
Published: (2016-09-01)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
by: Moses R
Published: (2010-05-01)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
by: Robert G Moses
Published: (2010-05-01)

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults
by: Molly G. Minze, et al.
Published: (2013-01-01)

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults
by: Molly G. Minze, et al.
Published: (2013-07-01)

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
by: Maffioli P, et al.
Published: (2011-06-01)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
by: Natalya Vladislavovna Zaytseva, et al.
Published: (2015-04-01)

Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China
by: Xingyun Hou, et al.
Published: (2019-05-01)

Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination
by: Panagoulias GS, et al.
Published: (2014-02-01)

Spotlight on the Low dose Rosiglitazone/ Metformin Combination In Prevention of Type 2 Diabetes
by: Muhammad Abdul Hadi
Published: (2010-01-01)

Spotlight on the Low dose Rosiglitazone/ Metformin Combination In Prevention of Type 2 Diabetes
by: Muhammad Abdul Hadi
Published: (2010-10-01)

Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
by: Chitrabhanu Ballav, et al.
Published: (2013-09-01)

Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
by: Chitrabhanu Ballav, et al.
Published: (2013-01-01)

Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
by: Ghim JL, et al.
Published: (2019-05-01)

New combination treatments in the management of diabetes: focus on sitagliptin – metformin
by: Jennifer Green, et al.
Published: (2008-08-01)

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
by: Derom E, et al.
Published: (2016-12-01)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
by: Paresh Ved, et al.
Published: (2012-01-01)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus′
by: Vishal Mundra
Published: (2012-01-01)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
by: Paresh Ved, et al.
Published: (2013-01-01)

Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study
by: Grigorios Rombopoulos, et al.
Published: (2015-01-01)

Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes.
by: Yoshinori Watanabe, et al.
Published: (2015-01-01)

Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes
by: Skelley JW, et al.
Published: (2018-12-01)

Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study
by: Banshi Saboo, et al.
Published: (2015-01-01)

SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
by: Seufert J
Published: (2015-11-01)

Patient profiling in diabetes and role of canagliflozin
by: Amblee A
Published: (2014-11-01)

Effect of canagliflozin alone and in combination with metformin on hormonal derangements and estrous cycle in a polycystic ovary syndrome rat model
by: Azam, N., et al.
Published: (2021)

Updated Review: Improved Glycemic Control with Repaglinide-Metformin in Fixed Combination for Patients with Type 2 Diabetes
by: John W. Richard, et al.
Published: (2011-01-01)

Canagliflozin and risk of amputation in patients with type 2 diabetes
by: T. M. Bukatina, et al.
Published: (2018-02-01)

Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus
by: Curtis Triplitt, et al.
Published: (2015-10-01)

Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus
by: Curtis Triplitt, et al.
Published: (2015-01-01)

Emerging treatments in type 2 diabetes: focus on canagliflozin
by: Rosiak M, et al.
Published: (2014-08-01)

Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets
by: Anteneh Belayneh, et al.
Published: (2020-01-01)

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
by: Schwartz SS, et al.
Published: (2016-03-01)